Bernardo Valdivieso

Bernardo Valdivieso

Auto-generated profile, based on publicly available information

Bernardo Valdivieso

Joint Research Unit in Biomedical Engineering (eRPSS: IIS La Fe-UPV), Valencia, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
MKMatthias Klumpp
Matthias Klumpp
MHMarcus Hintze
Marcus Hintze
IMImmonen Milla
Immonen Milla
Francisco Ródenas-RiglaFrancisco Ródenas-Rigla
Francisco Ródenas-Rigla
Francesco PilatiFrancesco Pilati
Francesco Pilati
RDRicard Delgado-Gonzalo
Ricard Delgado-Gonzalo
The development and implementation of artificial intelligence (AI) applications in health care contexts is a concurrent research and management question. Especially for hospitals, the expectations regarding improved efficiency and effectiveness by the introduction of novel AI applications are huge. However, experiences with real-life AI use cases are still scarce. As a first step towards structuring and comparing such experiences, this paper is presenting a comparative approach from nine European hospitals and eleven different use cases with possible application areas and benefits of hospital AI technologies. This is structured as a current review and opinion article from a diverse range of researchers and health care professionals. This contributes to important improvement options also for pandemic crises challenges, e.g., the current COVID-19 situation. The expected advantages as well as challenges regarding data protection, privacy, or human acceptance are reported. Altogether, the diversity of application cases is a core characteristic of AI applications in hospitals, and this requires a specific approach for successful implementation in the health care sector. This can include specialized solutions for hospitals regarding human–computer interaction, data management, and communication in AI implementation projects.

27 November 2018 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JHJavier Del Hoyo
Javier Del Hoyo
PNPilar Nos
Pilar Nos
RFRaquel Faubel
Raquel Faubel
DMDiana Muñoz
Diana Muñoz
DDDavid Domínguez
David Domínguez
MAMariam Aguas
Mariam Aguas
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Web-based systems provide safe and well-accepted management of mild to moderate inflammatory bowel disease (IBD) patients, with potential cost savings. However, the efficacy of different eHealth applications on disease outcomes is inconsistent between studies and data are lacking in complex IBD. Objective: To compare the impact on health outcomes and healthcare use of remote monitoring with a web system, TECCU (Telemonitorización de la Enfermedad de Crohn y Colitis Ulcerosa [Telemonitoring of Crohn’s Disease and Ulcerative Colitis]) in complex IBD patients vs standard care and telephone care. Methods: We performed a 3-arm randomized controlled trial (ClinicalTrials.gov identifier: NCT02943538). Adult IBD patients who initiated immunosuppressant and/or biological agents were recruited from the specialized IBD Unit of a public university hospital and then randomized to receive remote monitoring (G_TECCU), nurse-assisted telephone care (G_NT) or standard care with in-person visits (G_control). All patients attended study visits at baseline and at 12 and 24 weeks, in addition to each type of intervention. The primary outcome was the percentage of patients in remission at 24 weeks. Secondary health outcomes were quality of life, medication adherence, adverse effects, satisfaction and social activities. The number of outpatient visits and telephone calls, emergency visits, hospitalizations, IBD-related surgeries and corticosteroid courses were also collected. Results: In total, 63 patients were selected (21 in each group). During the study period, 90,5% of patients (19/21) in G_control, 95,2% of patients in G_AT (20/21) and 85,7% of patients in G_TECCU (18/21) were compliant to the intervention. After 24 weeks, the percentage of patients in remission was higher in G_TECCU (81%) compared with G_NT (66,7%) and G_control (71.4%), with a higherimprovement in disease activity in G_TECCU vs G_control both considering Harvey-Bradshaw/Mayo (OR= 0.12 [95% CI 0.003 to 2.162]; p=0.189) and Harvey-Bradshaw/Walmsley indexes (OR= 0.11 [95% CI 0.004 to 1.55]; p=0.126). Disease activity improvement was also associated to a higher reduction in fecal calprotectine values in G_TECCU vs G_control (estimated intervention effect -0.90 [95% CI -1.96 to 0.16]; p= 0.106) at the end of the study. All completer patients adhered to treatment in G_TECCU andquality of life, social activities and satisfaction improved in the 3 groups. The number of outpatient visits and telephone calls was lower in G_TECCU, with similar safety profile compared with G_NT and G_control. Conclusions: This pilot clinical trial suggests that TECCU is a safe strategy for improving health outcomes in complex IBD patients, with less frequent use of health care resources. Clinical Trial: ClinicalTrials.gov: NCT02943538; https://clinicaltrials.gov/ct2/show/NCT02943538 (Archived by WebCite at http://www.webcitation.org/6y4DQdmt8).

20 June 2017 in International Journal of Integrated Care
Verified
Journal Article
Open access
PDF file
STSalvador Tortajada
Salvador Tortajada
MGMaría Soledad Giménez-Campos
María Soledad Giménez-Campos
JVJulia Villar-López
Julia Villar-López
RFRaquel Faubel
Raquel Faubel
LDLucas Donat-Castelló
Lucas Donat-Castelló
JGJuan Miguel Garcia-Gomez
Juan Miguel Garcia-Gomez
In the past few years, healthcare systems have been facing a growing demand related to the high prevalence of chronic diseases. Case management programs have emerged as an integrated care approach for the management of chronic disease. Nevertheless, there is little scientific evidence on the impact of using a case management program for patients with complex multimorbidity regarding hospital resource utilisation. We evaluated an integrated case management intervention set up by community-based care at outpatient clinics with nurse case managers from a telemedicine unit. The hypothesis to be tested was whether improved continuity of care resulting from the integration of community-based and hospital services reduced the use of hospital resources amongst patients with complex multimorbidity. A retrospective cohort study was performed using a sample of 714 adult patients admitted to the program between January 2012 and January 2015. We found a significant decrease in the number of emergency room visits, unplanned hospitalizations, and length of stay, and an expected increase in the home care hospital-based episodes. These results support the hypothesis that case management interventions can reduce the use of unplanned hospital admissions when applied to patients with complex multimorbidity.

17 September 2020 in Sensors
Verified
Journal Article
Open access
PDF file
ZVZoe Valero-Ramon
Zoe Valero-Ramon
Carlos Fernandez-LlatasCarlos Fernandez-Llatas
Carlos Fernandez-Llatas
BVBernardo Valdivieso
Bernardo Valdivieso
Vicente TraverVicente Traver
Vicente Traver
Rich streams of continuous data are available through Smart Sensors representing a unique opportunity to develop and analyse risk models in healthcare and extract knowledge from data. There is a niche for developing new algorithms, and visualisation and decision support tools to assist health professionals in chronic disease management incorporating data generated through smart sensors in a more precise and personalised manner. However, current understanding of risk models relies on static snapshots of health variables or measures, rather than ongoing and dynamic feedback loops of behaviour, considering changes and different states of patients and diseases. The rationale of this work is to introduce a new method for discovering dynamic risk models for chronic diseases, based on patients’ dynamic behaviour provided by health sensors, using Process Mining techniques. Results show the viability of this method, three dynamic models have been discovered for the chronic diseases hypertension, obesity, and diabetes, based on the dynamic behaviour of metabolic risk factors associated. This information would support health professionals to translate a one-fits-all current approach to treatments and care, to a personalised medicine strategy, that fits treatments built on patients’ unique behaviour thanks to dynamic risk modelling taking advantage of the amount data generated by smart sensors.

5 November 2014
Verified
Book Chapter
Closed access
PDF file
Carlos Fernandez-LlatasCarlos Fernandez-Llatas
Carlos Fernandez-Llatas
BVBernardo Valdivieso
Bernardo Valdivieso
Vicente TraverVicente Traver
Vicente Traver
JBJose Miguel Benedi
Jose Miguel Benedi

6 April 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ARAlejandro Reina Reina
Alejandro Reina Reina
JBJosé M. Barrera
José M. Barrera
BVBernardo Valdivieso
Bernardo Valdivieso
MGMaría-Eugenia Gas
María-Eugenia Gas
AMAlejandro Maté
Alejandro Maté
JTJuan C. Trujillo
Juan C. Trujillo
Patients affected by SARS-COV-2 have collapsed healthcare systems around the world. Consequently, different challenges arise regarding the prediction of hospital needs, optimization of resources, diagnostic triage tools and patient evolution, as well as tools that allow us to analyze which are the factors that determine the severity of patients. Currently, it is widely accepted that one of the problems since the pandemic appeared was to detect (i) who patients were about to need Intensive Care Unit (ICU) and (ii) who ones were about not overcome the disease. These critical patients collapsed Hospitals to the point that many surgeries around the world had to be cancelled. Therefore, the aim of this paper is to provide a Machine Learning (ML) model that helps us to prevent when a patient is about to be critical. Although we are in the era of data, regarding the SARS-COV-2 patients, there are currently few tools and solutions that help medical professionals to predict the evolution of patients in order to improve their treatment and the needs of critical resources at hospitals. Moreover, most of these tools have been created from small populations and/or Chinese populations, which carries a high risk of bias. In this paper, we present a model, based on ML techniques, based on 5378 Spanish patients’ data from which a quality cohort of 1201 was extracted to train the model. Our model is capable of predicting the probability of death of patients with SARS-COV-2 based on age, sex and comorbidities of the patient. It also allows what-if analysis, with the inclusion of comorbidities that the patient may develop during the SARS-COV-2 infection. For the training of the model, we have followed an agnostic approach. We explored all the active comorbidities during the SARS-COV-2 infection of the patients with the objective that the model weights the effect of each comorbidity on the patient’s evolution according to the data available. The model has been validated by using stratified cross-validation with k = 5 to prevent class imbalance. We obtained robust results, presenting a high hit rate, with 84.16% accuracy, 83.33% sensitivity, and an Area Under the Curve (AUC) of 0.871. The main advantage of our model, in addition to its high success rate, is that it can be used with medical records in order to predict their diagnosis, allowing the critical population to be identified in advance. Furthermore, it uses the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD 9-CM) standard. In this sense, we should also emphasize that those hospitals using other encodings can add an intermediate layer business to business (B2B) with the aim of making transformations to the same international format.